Vaccine development during global epidemics: the Zika experience.

Castanha, Priscila M S; Marques, Ernesto T A

Castanha, Priscila M S; Marques, Ernesto T A.

Castanha PMS; Graduate School of Public Health, Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Marques ETA; Graduate School of Public Health, Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA 15261, USA. Electronic address: marques@pitt.edu.

Lancet Infect Dis ; 20(9): 998-999, 2020 09.

Article in English | MEDLINE | ID: covidwho-186283

Subject(s)

Epidemics; Zika Virus Infection/epidemiology; Zika Virus; Double-Blind Method; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Epidemics / Zika Virus / Zika Virus Infection Type of study: Observational study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2020 Document Type: Article Affiliation country: S1473-3099(20)30360-1

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google